Содержание преступного обращения ненадлежащей медицинской продукции

Алексей Иванович Рарог; Арсений Александрович Бимбинов

doi:10.21638/spbu14.2019.204

Authors

Алексей Иванович Рарог Kutafin Moscow State Law University (MSAL), 9, Sadovaya-Kudrinskaya ul., Moscow, 125993, Russian Federation
Арсений Александрович Бимбинов Moscow financial-industrial University “Synergy”, 80 g, Leningradsky pr., Moscow, 125993, Russian Federation

DOI:

https://doi.org/10.21638/spbu14.2019.204

Abstract

This article provides results of a study of addressing inappropriate medical products, the responsibility for which is provided by Article 2381 of the Criminal Code of the Russian Federation. On the basis of a system analysis of the doctrine of criminal law, regulatory legislation for the circulation of medical products and law-enforcement practices in criminal cases lead to conclusions about the maintenance of concepts of production, sale, and import, and also the moment of terminating these socially dangerous acts. According to Article 2381, production of medicines is occurs at any stage in the relevant technological process creating a ready-made product in a large quantity. Production of medical products represents any stage in the technological process that allows reception of a ready-made product in a large quantity. Production of dietary supplements containing pharmaceutical substances that are not stated in registration with the state represents any actions for processing input products, creating a ready-made product in a large quantity. Sale, according to Article 2381, is understood traditionally, as paid or gratuitous transfer (expropriation) of a subject of crime to other persons. Import into the territory of the Russian Federation of counterfeited, unregistered, or substandard medical products represents movement of the specified products through the frontier of the Russian Federation or customs border of the Eurasian Economic Union from outside the territory of the Russian Federation. Controversial issues about qualification of criminal handling of medical products are also considered. The existing judicial practice of qualifying the sale of counterfeited, substandard, or unregistered medicines or medical products carried out during the operational investigation “Test purchase”, as a completed crime, has no legislative or law-enforcement grounds.

Keywords:

forged, substandard, unregistered medicines, medical products, biologically active additives, sale, import, production, criminal liability

Downloads

Download data is not yet available.

References

Библиография

Годунов, Олег И. 2015. «Проблемные вопросы привлечения к уголовной ответственности за оборот фальсифицированных лекарств». Вестник Ивановского государственного университета. Серия: Естественные, общественные науки 2: 13–18.

Деревянская, Татьяна П. 2017. «Незаконное производство лекарственных средств и медицинских изделий в составе преступления, предусмотренного ст. 235.1 Уголовного кодекса РФ». Медицинское право 4: 28–31.

Ершова, Инна В., Константин А., Кошечкин, Вадим А. Меркулов и др. 2018. Жизненный цикл лекарственных средств. М.: Медицинское информационное агентство.

Лихолетов, Александр А. 2017. «Пути совершенствования уголовной ответственности за незаконное производство лекарственных средств и медицинских изделий» Российская юстиция 3: 28–31.

Путило, Наталья В. и др. 2017. Право граждан на лекарственное обеспечение. М.: Контракт.

Симонов, Вячеслав С., Мария Ю. Беликова. 2017. «Криминологические проблемы противодействия обороту фальсифицированных лекарственных средств». Научный вестник Невинномысского государственного гуманитарно-технического института 3: 10–18.

Фирсов, Илья В. 2017a. «Незаконный оборот медицинской продукции: уголовно-правовое исследование». Автореф. дис. … канд. юрид. наук, Московский государственный юридический университет им. О. Е. Кутафина (МГЮА).

Фирсов, Илья В. 2017b. «Незаконный оборот медицинской продукции: уголовно-правовое исследование». Дис. … канд. юрид. наук, Московский государственный юридический университет им. О. Е. Кутафина (МГЮА).

Фирсов, Илья В. 2016. «Объективные признаки преступления, предусмотренного ст. 238.1 Уголовного кодекса Российской Федерации». Общество и право 1 (55): 112–116.

Bansal, Devendra, Spundana Malla, Kapil Gudala, Indra P. Tiwari. 2013. “Anti-Counterfeit Technologies: A Pharmceutical Industry Perspective”. Sci Pharm 81 (1): 1–13.

Moore, Richard D., Richard E. Chaisson. 1999. “Natural history of HIV infection in the era of combination antiretroviral therapy”. AIDS 13 (14): 1933–1942.

Perelson, Alan S., Avidan U. Neumann, Martin Markowitz et al. 1996. “HIV-1 dynamics in vivo: Virion clearance rate, infected cell life-span, and viral generation time”. Science 271 (5255): 1582–1586.

Smyth, Redmond P., Miles P. Davenport, Mak Johnson. 2012. “The origin of genetic diversity in HIV-1”. Virus Research 169 (2): 415–429.

References

Bansal, Devendra, Spundana Malla, Kapil Gudala, Indra P. Tiwari. 2013. “Anti-Counterfeit Technologies: A Pharmceutical Industry Perspective”. Sci Pharm 81 (1): 1–13.

Derevianskaia, Tat’iana P. 2017. “Nezakonnoe proizvodstvo lekarstvennykh sredstv i meditsinskikh izdelii v sostave prestupleniia, predusmotrennogo st. 235.1 Ugolovnogo kodeksa RF” [“Illegal production of medicines and medical products in corpus delicti, the Criminal code of the Russian Federation provided by Art. 235.1”]. Meditsinskoe pravo [Medical right] 4: 28–31. (In Russian)

Ershova, Inna V., Konstantin A., Koshechkin, Vadim A. Merkulov et al. 2018. Zhiznennyi tsikl lekarstvennykh sredstv [Life cycle of medicines]. Moscow: Medical Information Publishing House. (In Russian)

Firsov, Il’ia V. 2016. “Objektivnye priznaki prestupleniia, predusmotrennogo statei 238.1 Ugolovnogo kodeksa Rossiiskoi Federatsii” [“Objective essential elements of offense, the Criminal Code of the Russian Federation provided by article 238.1”]. Obshchestvo i pravo [Society and right] 1 (55): 112–116.(In Russian)

Firsov, Il’ia V. 2017a. “Nezakonnyi oborot meditsinskoi produktsii: ugolovno-pravovoe issledovanie” [“Illicit trafficking in medical production: criminal and legal research”]. PhD diss. abstract, Moscow state law university of O. E. Kutafin (MSAL). (In Russian)

Firsov, Il’ia V. 2017b. “Nezakonnyi oborot meditsinskoi produktsii: ugolovno-pravovoe issledovanie” [“Illicit trafficking in medical production: criminal and legal research”]. PhD diss., Moscow state law university of O. E. Kutafin (MSAL). (In Russian)

Godunov, Oleg I. 2015. “Problemnye voprosy privlecheniia k ugolovnoi otvetstvennosti za oborot fal’sifitsirovannykh lekarstv” [“Problematic issues of criminal prosecution for turnover of the forged drugs”]. Vestnik Ivanovskogo gosudarstvennogo universiteta. Seriia: Estestvennye, obshchestvennye nauki [Bulletin of the Ivanovo state university. Series: Natural, social sciences] 2: 13–18. (In Russian)

Likholetov, Aleksandr A. 2017. “Puti sovershenstvovaniia ugolovnoi otvetstvennosti za nezakonnoe proizvodstvo lekarstvennykh sredstv i meditsinskikh izdelii” [“Ways of improvement of criminal responsibility for illegal production of medicines and medical products”]. Rossijskaia iustitsiia [Russian justice] 3: 28–31. (In Russian)

Moore, Richard D., Richard E. Chaisson. 1999. “Natural history of HIV infection in the era of combination antiretroviral therapy”. AIDS 13 (14): 1933–1942.

Perelson, Alan S., Avidan U. Neumann, Martin Markowitz et al. 1996. “HIV-1 dynamics in vivo: Virion clearance rate, infected cell life-span, and viral generation time”. Science 271 (5255): 1582–1586.

Putilo, Natal’ia V. et al. 2017. Pravo grazhdan na lekarstvennoe obespechenie [Right of citizens for medicinal providing]. Moscow: Contract Publ. (In Russian)

Simonov, Vyacheslav S., Maria Iu. Belikova. 2017. “Kriminologicheskie problemy protivodeistviia oborotu fal’sifitsirovannykh lekarstvennykh sredstv” [“Criminological problems of counteraction to a turnover of the forged medicines”]. Nauchnyi vestnik Nevinnomysskogo gosudarstvennogo gumanitarnotekhnicheskogo instituta [Scientific bulletin of the Nevinnomyssk state humanitarian and technical institute] 3: 10–18. (In Russian)

Smyth, Redmond P., Miles P. Davenport, Mak Johnson. 2012. “The origin of genetic diversity in HIV-1”. Virus Research 169 (2): 415–429.